The Best of AMCP Nexus 2019

AMCP has compiled the best sessions from AMCP Nexus 2019 for those of you who were not able to attend the meeting or those of you who attended but missed some of the sessions.  Here are the home study activities included in this set and ready to challenge and enhance your professional practice.

  1. Checking In on Health Care Reform Efforts: What Do They Mean for Payers, Manufacturers, and Patients?
  2. Fast and Furious: What is Driving the Specialty Spend?
  3. How Continued Drug Shortages Compromise Patient Care
  4. Increasing Positive Outcomes: The Impact of Social Determinants of Health
  5. Innovative Value-Based Contracting Approaches with Comprehensive Clinical Strategies
  6. Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements
  7. Real-Time Pharmacy Benefits: Results and Learnings from a Real-World Implementation
  8. Specialty Pharmaceuticals in Development
  9. The Managed Care Evaluation of Non-Alcoholic Steatohepatitis Treatment Options
  10. "The Times They Are a-Changin" – A Look at Congressional Efforts to Reform the Medicare and Medicaid Prescription Drug Programs

Pick and choose individual sessions from the catalog or purchase The Best of AMCP Nexus 2019: The Top Ten most highly rated sessions, according to attendance and post-meeting surveys.

Products

Found 10
Sort by
Nexus Conferences
Log In

The Times They Are a-Changin – A Look at Congressional Efforts to Reform the Medicare and Medicaid Prescription Drug Programs

Contact Hours: 1.5. For more than a decade, millions of American seniors have been able to access prescription drugs through market-driven programs.
Prescription Drug Program
Nexus Conferences
Log In

Specialty Pharmaceuticals in Development - Nexus 2019

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.
Specialty
Nexus Conferences
Log In

The Managed Care Evaluation of Non-Alcoholic Steatohepatitis Treatment Options

Contact Hours: 1.5. Non-alcoholic steatohepatitis (NASH) is a liver disease resulting from metabolic dysfunction that can lead to serious and costly health conditions, such as inflammation, hepatocellular injury, progressive fibrosis, and cirrhosis.
NASH
Nexus Conferences
Log In

Real-Time Pharmacy Benefits: Results and Learnings from a Real-World Implementation

Contact Hours: 1.5. Real-time pharmacy benefits (RTPB) deliver real-time access to medication pricing and restriction information at the point of prescribing.
Real-TIme Pharmacy
Nexus Conferences
Log In

Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements

Contact Hours: 1.5. The current understanding of Alzheimer’s disease is evolving.
Alzheimer's
Nexus Conferences
Log In

Innovative Value-Based Contracting Approaches with Comprehensive Clinical Strategies

Contact Hours: 1.5. Innovative approaches to developing value-based contracts in the market need to be multi-faceted.
Value-Based Contracting
Nexus Conferences
Log In

Increasing Positive Outcomes: The Impact of Social Determinants of Health

Contact Hours: 1.5. There is a growing body of evidence that highlights how social determinants of health—socioeconomic status, education, physical environment, employment, and social support networks—play a large role in determining overall health outcomes.
Social Determinants
Nexus Conferences
Log In

How Continued Drug Shortages Compromise Patient Care

Contact Hours: 1.5. Providing safe and effective drug therapy has become extremely challenging during extended periods of drug shortages.
Drug Shortages
Nexus Conferences
Log In

Fast and Furious: What is Driving the Specialty Spend?

Contact Hours: 1.5. In 2018, the United States spent an estimated $517 million on specialty drugs. While specialty medications make up only about 1–2 % of all prescriptions written, they account for nearly 50% of total drug spend.
Specialty Drug Spend
Nexus Conferences
Log In

Checking In on Health Care Reform Efforts: What Do They Mean for Payers, Manufacturers and Patients?

Contact Hours: 1.5. While broader drug pricing reform efforts have taken the lion’s share of attention in health policy discourse over the past year, the Trump Administration has continued to move forward with implementing changes to the Affordable Care Act (ACA).
Health Care Reform HCA